Evidence map›Paper›PMID 30809418›Full record

ArticleWorld journal of gastrointestinal pathophysiology2018

Role of

Tanya Kadiyska, Ivan Tourtourikov, Ana-Maria Popmihaylova, Hilda Kadian, Ani Chavoushian

Open access · diamondAbstract readEditorial
In one paragraph

Article in World journal of gastrointestinal pathophysiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in immunology · 2023
    Article
  8. Effects ofFrontiers in physiology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tanya KadiyskaDepartment of Medical Chemistry and Biochemistry, Sofia Medical University, Sofia 1431, Bulgaria.
Ivan TourtourikovGenetic Medico-Diagnostic Laboratory Genica, Sofia 1612, Bulgaria.
Ana-Maria PopmihaylovaUniversity of Montpellier, Montpellier 34090, France.
Hilda KadianBulgarian Association for Inflammatory Bowel Diseases, Sofia 1527, Bulgaria.
Ani ChavoushianDepartment of Gastroenterology, Acibadem City Clinic Oncology Center, Sofia 1784, Bulgaria.
Université de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal diseases, specifically Crohn's disease, ulcerative colitis, diverticular disease, and primary biliary cirrhosis are all characterized by complicated inflammation of the digestive tract. Their pathology is multifactorial, and risk factors encompass both genetic and environmental factors. Recent advances in the genetic component of inflammatory bowel diseases (IBDs) have revealed that the tumor necrosis factor superfamily member 15 (

Indexed as

Crohn’s diseaseDeath receptor 3Diverticular diseasePrimary biliary cirrhosisTumor necrosis factor superfamily member 15Ulcerative colitis

Identifiers

PMID30809418
PMCPMC6384511
OpenAlexW2901260432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.